LIVN, GB00BYMT0J19

LivaNova stock gains 1.81 percent before November results

Published on 10/06/2026 at 11:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

LivaNova stock was last at USD 76.43 on October 5, up 1.81 percent before its November 4 results date. Q2 revenue rose 10.8 percent year over year.

LIVN, GB00BYMT0J19, Illustration mit AI erstellt.
LIVN, GB00BYMT0J19, Illustration mit AI erstellt.

LivaNova (ISIN GB00BYMT0J19) stock was last at USD 76.43 on Nasdaq on October 5, 2026, up 1.81 percent from the prior close. The company will release its third-quarter 2026 results on November 4, 2026, according to a company announcement carried by StockTitan on September 23, 2026. The date gives the stock a defined checkpoint after its latest guidance increase.

Guidance moves higher for 2026

LivaNova's second-quarter revenue reached USD 390.59 million in the quarter ended June 30, 2026, up 10.8 percent from the prior-year period. Adjusted diluted EPS was USD 1.26, compared with USD 1.05 a year earlier, while the result exceeded the USD 1.09 consensus estimate, according to MarketBeat in its October 3, 2026 report.

The Q2 earnings call transcript shows that management raised full-year 2026 constant-currency revenue growth guidance to 8%-9% from 7%-8%. The company also projected adjusted diluted EPS of USD 4.30-4.40 and maintained adjusted operating margin guidance of 20%-21%, according to Yahoo Finance on August 5, 2026.

Consensus target sits above the stock

MarketBeat lists a Moderate Buy consensus from 11 analysts, with six Buy ratings and five Hold ratings. Its average price target is USD 84.12, which places the target 10.1 percent above the October 5 price of USD 76.43.

The operating picture is not cost-free. Management said adjusted free cash flow guidance was reduced to USD 140 million-160 million from USD 160 million-180 million as LivaNova invests in innovation, information technology and Cardiopulmonary capacity. That trade-off matters because the higher revenue outlook is being supported by spending intended to expand future production.

LivaNova stock reaches USD 76.43

LivaNova stock was last at USD 76.43 on Nasdaq at 4:00 p.m. ET on October 5, 2026. The session range was USD 74.95-76.91, the 52-week range was USD 48.82-85.76, volume was 558,944 shares and market capitalization was USD 4.2 billion.

LivaNova stock facts

  • Company: LivaNova PLC
  • ISIN: GB00BYMT0J19
  • Ticker: LIVN
  • Trading venue: NASDAQ
  • Price (as of October 5, 2026, 4:00 p.m. ET): USD 76.43
  • Market capitalization: USD 4.2 billion (as of October 5, 2026)
  • 52-week range: USD 48.82-85.76 (as of October 5, 2026)
  • Sector / Industry: Healthcare / Medical Devices

Upcoming dates for LivaNova stock

  • November 4, 2026: Third-quarter 2026 results and conference call

More news and analyses on LivaNova stock

Disclaimer...

en | GB00BYMT0J19 | LIVN | boerse | 70240781 | bgmi